Table 2 SLN detection and distribution of SLN stations
Patient id | Age/sex | Tumour type | Baseline SLN stations (N) | Baseline SLN station locations | Follow-up SLN stations (N) | Follow-up SLN station locations |
|---|---|---|---|---|---|---|
1 | M/69 | Adenocarcinoma | 2 | 111,112 | 0 | NA |
2 | M/70 | Adenocarcinoma | 2 | 111,2 | 1 | 16a2 |
3 | M/64 | Adenocarcinoma | 1 | 110 | 1 | 1 |
4 | F/68 | Adenocarcinoma | 1 | 112 | 2 | 109 L,110 |
5 | M/65 | Adenocarcinoma | 1 | 3 | 0 | NA |
6 | M/64 | Adenocarcinoma | 0 | NA | 1 | 1 |
7 | M/63 | Adenocarcinoma | 0 | NA | 2 | 107,109R |
8 | M/60 | Squamous cell carcinoma | 1 | 108 | 0 | NA |
9 | M/79 | Squamous cell carcinoma | 1 | 101 L | 1 | 101 L |
10 | M/54 | Adenocarcinoma | 2 | 109 L (2) | 2 | 105,111 |